Active	Status	Sponsor type	Region	Phase	Filter
3 Active 8 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Boulware, David R
EnACT3, NCT05541107: Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3	Not yet recruiting	3	270	NA	MAT2203, cAMB, Amphotericin B	Matinas BioPharma Nanotechnologies, Inc., University of Minnesota	Cryptococcal Meningitis	10/24	01/25
NCT06414512: Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis	Recruiting	2	36	RoW	AMBITION trial control, Flucytosine	University of Minnesota	Cryptococcal Meningitis	09/24	09/24
NCT04604561: Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses	Completed	N/A	50	US	EnVisio SmartClip, EnVisio™ Navigation System	H. Lee Moffitt Cancer Center and Research Institute, Elucent Medical	Breast Cancer	07/23	07/23